Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Adult Relapsed/Refractory ALL
NCT01401322Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in acute lymphoblastic leukemia (ALL), sponsored by Stanford University. Started Jan 2011; status: terminated.
02
Drugs
lenalidomide
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01401322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01401322.